Is Blackrock Going "Activist" With AstraZeneca?Mark Melin
Is the activist strategy spreading to traditional establishment investors such as BlackRock, Inc. (NYSE:BLK)?
Blackrock communicating its desires to AstraZeneca
BlackRock, Inc. (NYSE:BLK), the epitome of establishment institutional investing, may be finding its voice. The New York Times is reporting that BlackRock, AstraZeneca plc (ADR) (NYSE:AZN) (LON:AZN)’s largest shareholder, is making public its desire for the drug maker . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible